Anti-PKC delta (phospho S645) antibody [EP1486Y]
- BOND RX™ Validated
- RabMAb
- KO Validated
- What is this?
3
(3 Reviews)
|
(7 Publications)
Rabbit Monoclonal PKC delta phospho S645 antibody. Suitable for IHC-P, ELISA, Dot, WB and reacts with Human, Synthetic peptide, Synthetic peptide - Human samples. Cited in 7 publications.
View Alternative Names
PKCD, PRKCD, Protein kinase C delta type, Tyrosine-protein kinase PRKCD, nPKC-delta
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Immunohistochemical analysis of paraffin-embedded Human bladder carcinoma labeling PKC delta with ab108972 at 1/500 dilution (0.60 µg/ml). Positive staining on human bladder carcinoma without alkaline phosphatase treatment (image A). No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab108972 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Heat mediated antigen retrieval was performed with Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Immunohistochemical analysis of paraffin-embedded Human spleen carcinoma labeling PKC delta with ab108972 at 1/500 dilution (0.60 µg/ml). Positive staining on human spleen carcinoma without alkaline phosphatase treatment (image A). No signal was detected when tissues were treated with alkaline phosphatase (image B). The section was incubated with ab108972 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Heat mediated antigen retrieval was performed with Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Immunohistochemical analysis of PKC delta in paraffin embedded Human breast carcinoma tissue, using ab108972 at a 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Primary ab Dilution 1 : 100,000 dilution, Secondary ab description and code (ab id) Goat Anti-Rabbit IgG, (H+L), HRP conjugated (ab97051), Secondary ab dilution 1 : 20,000 dilution, Blocking buffer and concentration 5% NFDM/TBST, Diluting buffer and concentration 5% NFDM/TBST, Lane 1 : Untreated THP-1 (Human monocytic leukemia cell line) whole cell lysates 15ug, Lane 2 : THP-1 (Human monocytic leukemia cell line) treated with 50nM Calyculin A for 60 minutes whole cell lysates 15ug. Lane 3 : THP-1 (Human monocytic leukemia cell line) treated with 50nM Calyculin A for 60 minutes' whole cell lysates 15ug. Then the membrane was incubated with phosphatase. Lane 4 : None, Observed MW 78 kDa, Exposure time 5 seconds
All lanes:
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (ab108972)
Predicted band size: 78 kDa
false
- WB
Lab
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Primary ab Dilution 1 : 100,000 dilution, Secondary ab Goat Anti-Rabbit IgG, (H+L), HRP conjugated (ab97051), Secondary ab dilution 1 : 20,000 dilution,
Blocking buffer and concentration 5% NFDM/TBST, Diluting buffer and concentration 5% NFDM/TBST,
Lane 1 : THP-1 whole cell lysate treated with Calyculin A with no peptides,
Lane 2 : THP-1 whole cell lysate treated with Calyculin A with PKCd S645Pho peptides,
Lane 3 : THP-1 whole cell lysate treated with Calyculin A with PKCd unmodified peptides,
Observed MW 78 kDa,
Exposure time 10 seconds
All lanes:
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (ab108972)
Predicted band size: 78 kDa
false
- WB
Lab
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Lanes 1, 5 and 9 : Wild-type HAP1 cell lysate (20 μg)
Lanes 2, 6 and 10 : PKC delta knockout HAP1 cell lysate (20 μg)
Lanes 3, 7 and 11 : A431 cell lysate (20 μg)
Lanes 4, 8 and 12 : HeLa cell lysate (20 μg)
Lanes 1, 2, 3 and 4 : Green signal from target – ab108972 observed at 78 kDa
Lanes 5, 6, 7 and 8 : Red signal from loading control – ab8245 observed at 37 kDa
Lanes 9, 10, 11 and 12 : Merged (red and green) signal
ab108972 was shown to specifically react with PKC delta when PKC delta knockout samples were used. Wild-type and PKC delta knockout samples were subjected to SDS-PAGE. ab108972 and ab8245 (loading control to GAPDH) were diluted 1/10000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (ab108972)
Predicted band size: 78 kDa
false
- ELISA
Lab
ELISA - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Antigen PKCd S645Pho peptide, PKCd S645Pho unmodified peptide, Antigen concentration 1000ng/ml, Primary antibody concentration range 0~1000ng/ml, Secondary antibody Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L), Secondary antibody concentration 1 : 2500 dilution
- Dot
Lab
Dot Blot - Anti-PKC delta (phospho S645) antibody [EP1486Y] (AB108972)
Primary ab dilution 1 : 1000 dilution (2.355 μg /ml), Secondary ab description and code (ab id) Goat Anti-Rabbit IgG, (H+L), HRP conjugated (ab97051), Secondary ab dilution 1 : 100,000 dilution, Blocking buffer and concentration 5% NFDM/TBST, Diluting buffer and concentration 5% NFDM /TBST, Lane 1 : PKCd S645Pho peptides, Lane 2 : PKCd unmodified peptides, Lane 3 : None, Lane 4 : None, Observed MW N/A, Exposure time 3 minutes
Related conjugates and formulations (1)
-
Anti-PKC delta (phospho S645) antibody [EP1486Y] - BSA and Azide free
Reactivity data
Product details
This product has switched from a hybridoma to recombinant production method on 20th November 2023.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PKC delta influences cell growth apoptosis and differentiation through its kinase activity. It acts as an important regulator in the signaling pathways that control these processes. PKC delta is not a part of a traditional complex but interacts with several proteins influencing signaling cascades. In cellular contexts PKC delta positively influences tumor necrosis factor-related pathways and also initiates apoptosis in response to DNA damage.
Pathways
PKC delta plays an essential role in the regulation of mitogen-activated protein kinase (MAPK) and Janus kinase (JAK) pathways. Within the MAPK pathway PKC delta interacts with proteins like c-Jun N-terminal kinase (JNK) facilitating stress-responsive pathways related to cell death and survival. In the JAK pathway its regulation can impact cytokine signaling and immune responses. PKC delta's function within these pathways positions it as an important mediator and influencer of diverse cellular responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Gut microbes 17:2546158 PubMed40849919
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 16: PubMed39001513
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:312 PubMed33708939
2021
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medical journal : PubMed33031138
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 18:76 PubMed32429937
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 22:668-683 PubMed28994193
2017
Applications
WB
Species
Human
Cellular signalling 40:133-142 PubMed28927664
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com